Get real-time Minerva Surgical (UTRS) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.
Stock Price 0.01 About Minerva Surgical Minerva Surgical is a company focused on the development of minimally invasive devices for the treatment of Abnormal Uterine Bleeding (AUB) within the healthcare sector. The company offers a suite of devices designed to streamline and improve the safety, simpl...
Get the latest Minerva Surgical Inc. (UTRS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Minerva Surgical(UTRS.US):2022年Q4财报实现营收1380.4万美元,前值为1364.5万美元,预期值为1500万美元,比市场预期低7.97%;每股收益为-0.20美元,前值为-0.50美元,预期值为-0.28美元,超出市场预期28.57%。 Minerva Surgical(UTRS.US)公司简介:Minerva Surgical Inc 是一家商业阶段的医疗技术公司,专注于开发、制造和...
Minerva Surgical, Inc., a women's health company focused on the treatment of Abnormal Uterine Bleeding, announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of $12.00 per share.
semi-solid, liquid or gaseous forms such as tablets, capsules, powders, granules, ointments, solutions, depositories, inhalants and injections, and usual ways for oral, parenteral or surgical administration. The invention also embraces locally administering the compositions of the invention, including as...
A handful of property shares got a much-needed fillip in July 2008, chiefly driven by talk of a Minerva takeover and other stake-building among non-real estate investment trust (REIT) stock. In July, AIM-listed property shares took a battering, not helped by the collapse of financial ...